Harvard Bioscience Inc
HBIO- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001123494
No open-market purchases or sales by Harvard Bioscience Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $10.3M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Harvard Bioscience Inc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +5 vs. Q3 2021
- Shares held
- 30.0M
- +2.63M (+9.6%) vs. Q3 2021
- Total value
- $211.4M
- +$20.4M (+10.7%) vs. Q3 2021
- New holders
- 15
- 34 more added
- Sold out
- 10
- 34 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 37 | $10.3M |
| Q1 2026 | 37 | $7.73M |
| Q4 2025 | 64 | $11.7M |
| Q3 2025 | 61 | $7.29M |
| Q2 2025 | 69 | $8.39M |
| Q1 2025 | 92 | $14.5M |
| Q4 2024 | 96 | $65.5M |
| Q3 2024 | 95 | $84.2M |
| Q2 2024 | 100 | $90.7M |
| Q1 2024 | 90 | $137.8M |
| Q4 2023 | 93 | $176.4M |
| Q3 2023 | 94 | $141.6M |
| Q2 2023 | 100 | $178.2M |
| Q1 2023 | 66 | $127.2M |
| Q4 2022 | 68 | $83.3M |
| Q3 2022 | 79 | $74.0M |
| Q2 2022 | 91 | $106.8M |
| Q1 2022 | 98 | $187.3M |
| Q4 2021 | 103 | $211.4M |
| Q3 2021 | 99 | $191.7M |
| Q2 2021 | 99 | $232.3M |
| Q1 2021 | 87 | $144.2M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Harvard Bioscience Inc; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Punch & Associates Investment Management, Inc. | 2,166,775 | $15.3M | 0.80% | +545,000+33.6% | Added |
| Portolan Capital Management, LLC | 2,538,799 | $17.9M | 1.20% | +180,789+7.7% | Added |
| BlackRock Inc. | 3,063,190 | $21.6M | 0.00% | +325,723+11.9% | Added |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −403,291−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −170,580−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −15,799−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −14,820−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −13,135−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,645−100.0% | Sold out |
| Altshuler Shaham Ltd | 0 | $0 | 0.00% | −6,092−100.0% | Sold out |
| First Quadrant L P | 0 | $0 | 0.00% | −4,535−100.0% | Sold out |
| Trustcore Financial Services, LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −353−100.0% | Sold out |
| Adirondack Research & Management Inc. | – | – | – | – | Not filed |